CCDC61
gene geneOn this page
Also known as VFL3hVFL3
Summary
CCDC61 (coiled-coil domain containing 61, HGNC:33629) is a protein-coding gene on chromosome 19q13.32, encoding Centrosomal protein CCDC61 (Q9Y6R9). Microtubule-binding centrosomal protein required for centriole cohesion, independently of the centrosome-associated protein/CEP250 and rootletin/CROCC linker.
Enables identical protein binding activity and microtubule binding activity. Involved in centriole assembly and mitotic spindle assembly. Located in centriolar satellite and ciliary basal body. Part of centriolar subdistal appendage.
Source: NCBI Gene 729440 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 21 total — 1 pathogenic
- MANE Select transcript:
NM_001267723
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33629 |
| Approved symbol | CCDC61 |
| Name | coiled-coil domain containing 61 |
| Location | 19q13.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | VFL3, hVFL3 |
| Ensembl gene | ENSG00000104983 |
| Ensembl biotype | protein_coding |
| OMIM | 620676 |
| Entrez | 729440 |
Gene structure
Transcript identifiers
Ensembl transcripts: 25 — 21 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000536603, ENST00000594087, ENST00000594672, ENST00000595358, ENST00000596161, ENST00000596687, ENST00000599044, ENST00000601763, ENST00000897318, ENST00000897319, ENST00000897320, ENST00000897321, ENST00000897322, ENST00000897323, ENST00000897324, ENST00000916385, ENST00000916386, ENST00000916387, ENST00000916388, ENST00000959914, ENST00000959915, ENST00000959916, ENST00000959917, ENST00000959918, ENST00000959919
RefSeq mRNA: 1 — MANE Select: NM_001267723
NM_001267723
CCDS: CCDS46120
Canonical transcript exons
ENST00000595358 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000713753 | 46017247 | 46017304 |
| ENSE00000713785 | 46018078 | 46018150 |
| ENSE00000713800 | 46018290 | 46018616 |
| ENSE00000858273 | 46015345 | 46015427 |
| ENSE00000858275 | 46016318 | 46016393 |
| ENSE00000858276 | 46016694 | 46016833 |
| ENSE00000858277 | 46016991 | 46017069 |
| ENSE00003054228 | 45995467 | 45995504 |
| ENSE00003217843 | 46016054 | 46016223 |
| ENSE00003531910 | 46006559 | 46006716 |
| ENSE00003596671 | 46003008 | 46003166 |
| ENSE00003674844 | 46015049 | 46015259 |
| ENSE00003686281 | 46008140 | 46008301 |
| ENSE00003790586 | 46003419 | 46003501 |
Expression profiles
Bgee: expression breadth ubiquitous, 173 present calls, max score 95.94.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.1160 / max 81.2498, expressed in 1734 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176518 | 6.1160 | 1734 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 95.94 | gold quality |
| right testis | UBERON:0004534 | 90.84 | gold quality |
| left testis | UBERON:0004533 | 90.65 | gold quality |
| granulocyte | CL:0000094 | 87.83 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 87.72 | gold quality |
| testis | UBERON:0000473 | 86.98 | gold quality |
| adenohypophysis | UBERON:0002196 | 86.03 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 85.78 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 84.99 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 84.75 | gold quality |
| cerebellar cortex | UBERON:0002129 | 84.51 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 84.33 | gold quality |
| pituitary gland | UBERON:0000007 | 84.11 | gold quality |
| right adrenal gland | UBERON:0001233 | 83.91 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 83.71 | gold quality |
| left ovary | UBERON:0002119 | 83.70 | gold quality |
| right ovary | UBERON:0002118 | 83.37 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 83.33 | gold quality |
| body of stomach | UBERON:0001161 | 83.25 | gold quality |
| left adrenal gland | UBERON:0001234 | 83.13 | gold quality |
| transverse colon | UBERON:0001157 | 83.07 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 82.92 | gold quality |
| left uterine tube | UBERON:0001303 | 82.84 | gold quality |
| spleen | UBERON:0002106 | 82.72 | gold quality |
| body of uterus | UBERON:0009853 | 82.69 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 82.66 | gold quality |
| cerebellum | UBERON:0002037 | 82.51 | gold quality |
| lower esophagus | UBERON:0013473 | 82.34 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 82.33 | gold quality |
| right lobe of liver | UBERON:0001114 | 82.24 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.26 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- Ccdc61 controls centrosomal localization of Cep170 and is required for spindle assembly and symmetry. (PMID:30354798)
- hVFL3/CCDC61 is the human orthologue of proteins required for anchoring distinct sets of cytoskeletal fibers to centrioles in unicellular eukaryotes. (PMID:31789463)
- CCDC61/VFL3 Is a Paralog of SAS6 and Promotes Ciliary Functions. (PMID:32375023)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ccdc61 | ENSDARG00000062307 |
| mus_musculus | Ccdc61 | ENSMUSG00000074358 |
| rattus_norvegicus | Ccdc61 | ENSRNOG00000013767 |
Paralogs (1): SPTY2D1 (ENSG00000179119)
Protein
Protein identifiers
Centrosomal protein CCDC61 — Q9Y6R9 (reviewed: Q9Y6R9)
Alternative names: Coiled-coil domain-containing protein 61, VFL3 homolog
All UniProt accessions (3): Q9Y6R9, M0QY15, M0QYL5
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule-binding centrosomal protein required for centriole cohesion, independently of the centrosome-associated protein/CEP250 and rootletin/CROCC linker. In interphase, required for anchoring microtubule at the mother centriole subdistal appendages and for centrosome positioning. During mitosis, may be involved in spindle assembly and chromatin alignment by regulating the organization of spindle microtubules into a symmetrical structure. Has been proposed to play a role in CEP170 recruitment to centrosomes. However, this function could not be confirmed. Plays a non-essential role in ciliogenesis.
Subunit / interactions. Forms homodimers (via head domain). Interacts with CEP170. Interacts with PCM1 and CEP131. Binds tubulin.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Centriolar satellite. Cilium basal body.
Domain organisation. The coiled-coil domains are involved in microtubule-binding.
Miscellaneous. The N-terminal 3D structure (head domain) resembles that of NHEJ1/XLF, PAXX, SASS6 and XRCC4.
Similarity. Belongs to the CCDC61 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9Y6R9-1 | 1 | yes |
| Q9Y6R9-2 | 2 |
RefSeq proteins (1): NP_001254652* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR049733 | CCDC61_N | Domain |
UniProt features (35 total): modified residue 8, strand 7, mutagenesis site 6, helix 3, region of interest 2, sequence conflict 2, coiled-coil region 2, compositionally biased region 2, chain 1, splice variant 1, turn 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6HXT | X-RAY DIFFRACTION | 2.55 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y6R9-F1 | 71.97 | 0.40 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (8): 336, 373, 376, 447, 473, 1, 285, 334
Mutagenesis-validated functional residues (6):
| Position | Phenotype |
|---|---|
| 128–129 | loss of dimerization. |
| 259 | loss of microtubule-binding; when associated with e-263, e-266, e-268 and e-270. |
| 263 | loss of microtubule-binding; when associated with e-259, e-266, e-268 and e-270. |
| 266 | loss of microtubule-binding; when associated with e-259, e-263, e-268 and e-270. |
| 268 | loss of microtubule-binding; when associated with e-259, e-263, e-266 and e-270. |
| 270 | loss of microtubule-binding; when associated with e-259, e-263, e-266 and e-268. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 80 (showing top):
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP, GOBP_CHROMOSOME_ORGANIZATION, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_CENTRIOLE_ASSEMBLY, GOBP_MITOTIC_SPINDLE_ASSEMBLY, GOBP_ORGANELLE_FISSION, GOCC_CENTROSOME, GOBP_MITOTIC_NUCLEAR_DIVISION, GOBP_ORGANELLE_ASSEMBLY, GOBP_MITOTIC_CELL_CYCLE, GOBP_SPINDLE_ASSEMBLY, GOBP_CELL_PROJECTION_ORGANIZATION, GOBP_NUCLEAR_CHROMOSOME_SEGREGATION, GOCC_CILIUM, GOBP_CELL_CYCLE_PROCESS
GO Biological Process (3): cell projection organization (GO:0030030), mitotic spindle assembly (GO:0090307), centriole assembly (GO:0098534)
GO Molecular Function (3): microtubule binding (GO:0008017), identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (8): centrosome (GO:0005813), microtubule organizing center (GO:0005815), centriolar satellite (GO:0034451), ciliary basal body (GO:0036064), centriolar subdistal appendage (GO:0120103), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| microtubule organizing center | 2 |
| cilium | 2 |
| cellular component organization | 1 |
| mitotic sister chromatid segregation | 1 |
| mitotic spindle organization | 1 |
| spindle assembly | 1 |
| mitotic nuclear division | 1 |
| microtubule organizing center organization | 1 |
| membraneless organelle assembly | 1 |
| tubulin binding | 1 |
| protein binding | 1 |
| binding | 1 |
| centriole | 1 |
| microtubule cytoskeleton | 1 |
| centrosome | 1 |
| intracellular protein-containing complex | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
696 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC61 | CEP20 | Q96NB1 | 626 |
| CCDC61 | CCDC138 | Q96M89 | 591 |
| CCDC61 | LRRCC1 | Q9C099 | 586 |
| CCDC61 | TBC1D31 | Q96DN5 | 553 |
| CCDC61 | HIC2 | Q96JB3 | 542 |
| CCDC61 | TTLL5 | Q6EMB2 | 539 |
| CCDC61 | FNDC4 | Q9H6D8 | 536 |
| CCDC61 | ERGIC2 | Q96RQ1 | 531 |
| CCDC61 | PIBF1 | Q8WXW3 | 498 |
| CCDC61 | PNPO | Q9NVS9 | 476 |
| CCDC61 | BRICD5 | Q6PL45 | 468 |
| CCDC61 | ZNF382 | Q96SR6 | 458 |
| CCDC61 | PNKP | Q96T60 | 428 |
| CCDC61 | VSX2 | P58304 | 416 |
| CCDC61 | CCDC63 | Q8NA47 | 415 |
IntAct
43 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MED4 | MED19 | psi-mi:“MI:2364”(proximity) | 0.900 |
| CEP290 | CCP110 | psi-mi:“MI:2364”(proximity) | 0.890 |
| CSNK1E | PER1 | psi-mi:“MI:0914”(association) | 0.840 |
| CEP170 | CCDC61 | psi-mi:“MI:0915”(physical association) | 0.540 |
| CEP170 | CCDC61 | psi-mi:“MI:0403”(colocalization) | 0.540 |
| CCDC13 | CEP290 | psi-mi:“MI:0914”(association) | 0.460 |
| PCM1 | CCDC61 | psi-mi:“MI:0915”(physical association) | 0.460 |
| CEP131 | CCDC61 | psi-mi:“MI:0915”(physical association) | 0.460 |
| CCDC61 | PCM1 | psi-mi:“MI:0403”(colocalization) | 0.460 |
| Cep135 | psi-mi:“MI:0914”(association) | 0.350 | |
| Nedd1 | psi-mi:“MI:0914”(association) | 0.350 | |
| Cep152 | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.350 |
| Cep120 | TBC1D31 | psi-mi:“MI:0914”(association) | 0.350 |
| CEP43 | CCHCR1 | psi-mi:“MI:0914”(association) | 0.350 |
| Cep131 | WBP2 | psi-mi:“MI:0914”(association) | 0.350 |
| Cep55 | UMAD1 | psi-mi:“MI:0914”(association) | 0.350 |
| OFD1 | CCDC14 | psi-mi:“MI:0914”(association) | 0.350 |
| CEP135 | TBC1D31 | psi-mi:“MI:0914”(association) | 0.350 |
| PPP2CB | DKFZP586J0619 | psi-mi:“MI:0914”(association) | 0.350 |
| ZBTB33 | SF3B1 | psi-mi:“MI:0914”(association) | 0.350 |
| Cep43 | TBC1D31 | psi-mi:“MI:0914”(association) | 0.350 |
| Ankrd26 | TBC1D31 | psi-mi:“MI:0914”(association) | 0.350 |
| Mib1 | TBC1D31 | psi-mi:“MI:0914”(association) | 0.350 |
| Prkar2a | TBC1D31 | psi-mi:“MI:0914”(association) | 0.350 |
| Sdccag8 | EEF1E1 | psi-mi:“MI:0914”(association) | 0.350 |
| Lrrcc1 | CCDC14 | psi-mi:“MI:0914”(association) | 0.350 |
| Cep72 | TBC1D31 | psi-mi:“MI:0914”(association) | 0.350 |
| PPP2R5D | CCHCR1 | psi-mi:“MI:0914”(association) | 0.350 |
| Pcm1 | TBC1D31 | psi-mi:“MI:0914”(association) | 0.350 |
| KIF7 | TBC1D31 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (46): CCDC61 (Proximity Label-MS), CCDC61 (Affinity Capture-MS), CCDC61 (Proximity Label-MS), CCDC61 (Affinity Capture-MS), CCDC61 (Affinity Capture-MS), CCDC61 (Affinity Capture-MS), CCDC61 (Affinity Capture-MS), CCDC61 (Affinity Capture-MS), CCDC61 (Affinity Capture-MS), CCDC61 (Affinity Capture-MS), CCDC61 (Affinity Capture-MS), CCDC61 (Affinity Capture-MS), CCDC61 (Affinity Capture-MS), CCDC61 (Affinity Capture-MS), CCDC61 (Affinity Capture-MS)
ESM2 similar proteins: A0JNT9, A0JPP8, A1X157, O15169, O75145, O75335, P39880, P60469, Q07DZ5, Q08CF3, Q08E13, Q09YM8, Q2M1P5, Q2QLG9, Q2VUH7, Q32PN7, Q3TMW1, Q3UHC7, Q3UIL6, Q3UIW5, Q3UJV1, Q5DU25, Q5FWS6, Q5JU85, Q5PRF9, Q5XI59, Q5ZJ07, Q674X7, Q68UI8, Q69ZS8, Q6IPM2, Q6NZT2, Q6P402, Q6P730, Q6ZP65, Q80XS6, Q80Y83, Q8JZP9, Q8K1S6, Q8R4R9
Diamond homologs: A0JPP8, Q08CF3, Q3UJV1, Q5ZJ07, Q68UI8, Q9Y6R9
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 57 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Loss of Nlp from mitotic centrosomes | 8 | 47.0× | 2e-10 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 8 | 47.0× | 2e-10 |
| AURKA Activation by TPX2 | 8 | 45.1× | 2e-10 |
| Recruitment of mitotic centrosome proteins and complexes | 8 | 40.3× | 5e-10 |
| Anchoring of the basal body to the plasma membrane | 9 | 37.7× | 2e-10 |
| Regulation of PLK1 Activity at G2/M Transition | 8 | 37.6× | 7e-10 |
| Recruitment of NuMA to mitotic centrosomes | 8 | 34.5× | 1e-09 |
| Mitotic Prometaphase | 6 | 15.4× | 5e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cilium assembly | 7 | 14.3× | 1e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
21 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 4 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 57097 | GRCh38/hg38 19q13.32(chr19:45595873-46600026)x1 | Pathogenic |
SpliceAI
2167 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:46003150:C:T | donor_gain | 1.0000 |
| 19:46003162:TGGCT:T | donor_gain | 1.0000 |
| 19:46003163:GGCT:G | donor_gain | 1.0000 |
| 19:46003163:GGCTG:G | donor_gain | 1.0000 |
| 19:46003164:GCT:G | donor_gain | 1.0000 |
| 19:46003164:GCTG:G | donor_gain | 1.0000 |
| 19:46003167:G:GG | donor_gain | 1.0000 |
| 19:46003417:A:AG | acceptor_gain | 1.0000 |
| 19:46003418:G:GG | acceptor_gain | 1.0000 |
| 19:46003418:GTC:G | acceptor_gain | 1.0000 |
| 19:46003498:TCAG:T | donor_loss | 1.0000 |
| 19:46003499:CAGG:C | donor_loss | 1.0000 |
| 19:46003500:AGG:A | donor_loss | 1.0000 |
| 19:46003501:GGTA:G | donor_loss | 1.0000 |
| 19:46003502:GTAGG:G | donor_loss | 1.0000 |
| 19:46003503:T:A | donor_loss | 1.0000 |
| 19:46006558:GA:G | acceptor_gain | 1.0000 |
| 19:46006558:GAGTA:G | acceptor_gain | 1.0000 |
| 19:46006713:ACAG:A | donor_loss | 1.0000 |
| 19:46006714:CAG:C | donor_loss | 1.0000 |
| 19:46006715:AG:A | donor_loss | 1.0000 |
| 19:46006717:G:A | donor_loss | 1.0000 |
| 19:46008297:GAGCA:G | donor_gain | 1.0000 |
| 19:46008299:GCA:G | donor_gain | 1.0000 |
| 19:46008302:G:GG | donor_gain | 1.0000 |
| 19:46015045:CCAGG:C | acceptor_loss | 1.0000 |
| 19:46015046:CAG:C | acceptor_loss | 1.0000 |
| 19:46015047:A:AG | acceptor_gain | 1.0000 |
| 19:46015047:A:T | acceptor_loss | 1.0000 |
| 19:46015047:AG:A | acceptor_gain | 1.0000 |
AlphaMissense
3261 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:46003142:T:A | W42R | 1.000 |
| 19:46003142:T:C | W42R | 1.000 |
| 19:46003144:G:C | W42C | 1.000 |
| 19:46003144:G:T | W42C | 1.000 |
| 19:46003445:G:T | G59W | 1.000 |
| 19:46003446:G:A | G59E | 1.000 |
| 19:46003446:G:T | G59V | 1.000 |
| 19:46003450:C:A | N60K | 1.000 |
| 19:46003450:C:G | N60K | 1.000 |
| 19:46003454:A:G | K62E | 1.000 |
| 19:46003456:A:C | K62N | 1.000 |
| 19:46003456:A:T | K62N | 1.000 |
| 19:46003469:T:C | F67L | 1.000 |
| 19:46003470:T:C | F67S | 1.000 |
| 19:46003471:C:A | F67L | 1.000 |
| 19:46003471:C:G | F67L | 1.000 |
| 19:46003479:T:C | M70T | 1.000 |
| 19:46003480:G:A | M70I | 1.000 |
| 19:46003480:G:C | M70I | 1.000 |
| 19:46003480:G:T | M70I | 1.000 |
| 19:46003491:C:A | A74D | 1.000 |
| 19:46006572:T:A | V82D | 1.000 |
| 19:46006584:T:C | L86P | 1.000 |
| 19:46006587:T:C | L87P | 1.000 |
| 19:46006602:T:A | L92Q | 1.000 |
| 19:46006602:T:C | L92P | 1.000 |
| 19:46006682:T:C | Y119H | 1.000 |
| 19:46006682:T:G | Y119D | 1.000 |
| 19:46006686:T:C | L120P | 1.000 |
| 19:46006689:T:A | I121N | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000157749 (19:46004180 T>C), RS1000208906 (19:46002047 G>A), RS1000233963 (19:46011954 C>T), RS1000373208 (19:46002067 C>T), RS1000468994 (19:46012679 A>G), RS1000594254 (19:46008557 C>T), RS1000645324 (19:46008373 G>A,T), RS1000675954 (19:46018004 T>C), RS1000757134 (19:46014296 C>T), RS1000767395 (19:46011611 G>A,T), RS1000861953 (19:45997002 G>A,C), RS1000942758 (19:45997389 A>G,T), RS1000946379 (19:46003480 G>C), RS1001003323 (19:45997195 C>G), RS1001162331 (19:46003809 G>A,C)
Disease associations
OMIM: gene MIM:620676 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007576_412 | Chronotype | 2.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008328 | chronotype measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| beta-lapachone | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| bisphenol S | decreases expression, affects cotreatment | 1 |
| jinfukang | increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Caffeine | affects phosphorylation | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Lead | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Testosterone | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.